Liezl Gambe

EPAM Systems (NYSE:EPAM) delivered a robust fourth-quarter performance, signaling that its aggressive pivot into "AI-native" services is paying off as the company closes out a pivotal fiscal year.

US-listed spot Bitcoin ETFs saw $133.3 million in net outflows on Wednesday, pushing weekly losses to $238 million as Bitcoin briefly fell below $66,000 amid persistent negative sentiment.

Fortuna Mining (NYSE:FSM) capped a transformative fiscal year with record-breaking cash flow, signaling a successful pivot toward its high-margin West African gold assets even as it wrestled with operational hurdles in Latin America.

The Ethereum Foundation has outlined quantum security, higher gas limits and improved cross-chain usability as key protocol priorities for 2026, following what it called one of its “most productive years” in 2025.

European Central Bank President Christine Lagarde is reportedly weighing an early departure before her term ends in October 2027, potentially reshaping the ECB’s leadership during a critical phase for the digital euro.

Societe Generale’s digital asset arm, SG-FORGE, has launched its euro-denominated stablecoin EUR CoinVertible on the XRP Ledger, marking its third public blockchain deployment after Ethereum and Solana.

Telecom giant Telstra (ASX:TLS) booked a 9.4% rise in interim net profit to $1.1 billion, underpinned by a disciplined focus on cost reduction.

Cinemark Holdings (NYSE;CNK) reported fourth-quarter 2025 net income attributable to the company of $34.1 million, or 16 cents per diluted share, compared with a net loss in the year-ago period.

Cyclopharm (ASX:CYC) announced the approval of its flagship technology, Technegas, for clinical use at the National Institutes of Health.

Telix Pharmaceuticals (ASX:TLX) submitted a Marketing Authorisation Application in Europe for its glioma imaging candidate, TLX101-Px.